>
API
CDMO
About us
Services
Contact supplier
Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH APIs on PharmaofferChemisch-pharmazeutisches Labor, Rolf Sachse GmbH_1Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH_2
Show all images

CPL Sachse - CDMO/CMO

We are an established order and contract manufacturer of active pharmaceutical ingredients (drug substances) and selected intermediates ranging from milligrams to kilograms. Our production follows cGMP and is in accordance with the EU-GMP-Guideline Part II (ICH Q7). We are regularly inspected by the responsible local authority which issues us with drug substance-specific GMP certificates. We are currently manufacturing nine certified APIs for market supplies exclusively for our customers on a regular basis.

 

Synthesis development

We have more than 30 years of experience in the development of organic syntheses for drug substances (APIs). On receipt of an order for synthesis development, we first research the latest state-of-the-art and conduct a feasibility study if applicable. This includes the proposed synthetic route, a schedule, and...

Address: Stieffring 14, 13627, Berlin
Germany
Germany Local time:

Visit website

Modern GMP facility

Team of academics and technical experts

Small to large batch sizes possible

Our services:

Drug Substance
Drug Product

Production scale:

small
Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Currently Rephine has no report for this supplier. Contact them to let them know you're interested!

Response time:

Contact supplier
Employees:
30+
Established in:
1982

Services

Drug Substance (CDMO/CRO)

Intermediates
Pharmaceutical intermediates are compounds used in the production of APIs. CDMOs play a crucial role in synthesizing, scaling, and ensuring the quality of these intermediate compounds to support efficient drug manufacturing.
Contact supplier

Replies quickly

Small Molecule APIs
Small molecule APIs form the backbone of many pharmaceutical drugs due to their low molecular weight and ease of synthesis. They are widely used in treating a range of diseases and are typically produced through chemical synthesis in GMP-compliant facilities.
Contact supplier

Replies quickly

Drug Product (CMO)

Liquid Oral products
Liquid oral products such as syrups and suspensions are used for pediatric and geriatric patients. CMOs offer formulation, mixing, filling, and packaging solutions for liquid drug products.
Contact supplier

Replies quickly

Contact Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH for Contract Services Expertise

Connect with Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH, a leading pharmaceutical company from Germany. They offer specialized Drug Substance (CDMO/CRO), Drug Product (CMO). Contact Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.


Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.


Key Functions of Drug Substance CDMOs/CROs:


  • API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.

  • Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.

  • GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.

  • Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.

  • Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.


Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.

Drug Product (CMO)

Drug Product CMOs focus on the manufacturing and packaging of finished pharmaceutical dosage forms. These contract partners provide scalable production solutions that meet global regulatory and quality standards, supporting pharma companies throughout the drug product lifecycle.


Pharmaoffer’s Drug Product CMO category includes providers capable of manufacturing oral solids, injectables, topical formulations, and more—whether for clinical trials or commercial distribution.


Key Functions of Drug Product CMOs:


  • Formulation Development: Supporting the transition from drug substance to drug product through formulation optimization and compatibility testing.

  • Clinical and Commercial Manufacturing: Offering pilot-scale to high-volume manufacturing for various dosage forms under GMP conditions.

  • Packaging and Serialization: Providing primary and secondary packaging with serialization and tamper-proof labeling to meet compliance requirements.

  • Regulatory Support: Ensuring that all production meets FDA, EMA, and ICH standards for drug product quality, safety, and traceability.

  • Flexible Production Lines: Handling diverse dosage forms including tablets, softgels, liquids, and sterile injectables.


Partner with Proven Drug Product CMOs

Through Pharmaoffer, discover CMOs that excel in drug product manufacturing. Whether you need small-scale batches or full commercial output, our platform connects you with the right partners for compliant, cost-effective solutions.

CPL Sachse

We are an established order and contract manufacturer of active pharmaceutical ingredients (drug substances) and selected intermediates ranging from milligrams to kilograms. Our production follows cGMP and is in accordance with the EU-GMP-Guideline Part II (ICH Q7). We are regularly inspected by the responsible local authority which issues us with drug substance-specific GMP certificates. We are currently manufacturing nine certified APIs for market supplies exclusively for our customers on a regular basis.

 

Synthesis development

We have more than 30 years of experience in the development of organic syntheses for drug substances (APIs). On receipt of an order for synthesis development, we first research the latest state-of-the-art and conduct a feasibility study if applicable. This includes the proposed synthetic route, a schedule, and a cost estimate for the execution of the necessary development work. It may also include an estimate of the future manufacturing costs for the drug substance.

 

Analytical development

In addition to the synthesis and drug development, we offer a comprehensive range of analytical services (incl. stability testing). Our range includes both routine analyses according to pharmacopoeial methods as well as the development of new analytical methods for drug substances and drug products. We have many years of experience in using gas chromatography (GC/MS, GC/FID) to determine residual solvents in pharmaceutical ingredients, drug substances (APIs), and drug products.